SCHEMBL4661872

SCHEMBL4661872

COc1ncc(NC(=O)Nc2ccc(F)cc2)cc1-c1c(Cl)cnn1C

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.63
HTR2C P28335 19/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4660710 0.93 HTR2A (0.74) HTR2AHTR2C
SCHEMBL4660580 0.90 HTR2A (0.61) HTR2AHTR2C
SCHEMBL4660639 0.89 HTR2A (0.66) HTR2AHTR2C
SCHEMBL4661776 0.89 HTR2A (0.77) HTR2AHTR2C
SCHEMBL4660702 0.89 HTR2A (0.52) HTR2AHTR2C
SCHEMBL4660682 0.88 HTR2A (0.76) HTR2AHTR2C
SCHEMBL5056337 0.86 HTR2A (0.84) HTR2AHTR2C
SCHEMBL4659379 0.83 HTR2A (0.52) HTR2AHTR2C
SCHEMBL15248540 0.83 HTR2A (0.62) HTR2AHTR2C
SCHEMBL4659226 0.82 HTR2A (0.74) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004627-A2 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2008-12-24 EP claimed
WO-2007120600-A2 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-10-25 WO claimed
EP-2004627-A2 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2008-12-24 EP disclosed
WO-2007120600-A2 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-10-25 WO disclosed